The regulatory authorizations come as Medtronic looks to differentiate itself in the fast-growing pulsed field ablation ...

Medtronic's latest regulatory wins further support its fast-growing arrhythmia-treating cardiac ablation business.

Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced regulatory milestones for software used with two cardiac ablation platforms. This includes U.S. Food and Drug ...

The new regulatory approvals expand Medtronic’s mapping and tissue-proximity capabilities for cardiac ablation.

(RTTNews) - Boston Scientific Corp. (BSX) said it has received U.S. Food and Drug Administration approval for the navigation-enabled FARAWAVE NAV Ablation Catheter for the treatment of paroxysmal ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Tailored ablation guided by AI better prevented atrial ...

A rare case report shows that an epicardial muscular connection bypassing ablation scars drove atrial fibrillation recurrence ...

GALWAY, Ireland, Aug. 6, 2026 /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced an expanded CE Mark indication for the Affera™ Mapping and Ablation ...

A new study published in the journal of Heart Rhythm O2 showed that performing right atrial (RA) linear ablation with a ...

New FARAWAVE™ NAV Ablation Catheter and FARAVIEW™ Software combine with OPAL HDx™ Mapping System to provide visualization during pulsed field ablation Today, physicians may utilize a separate mapping ...